Therapy Areas: AIDS & HIV
17 January 2020 - ViiV Healthcare, a specialist HIV company, has received approval from The Japan Ministry of Health, Labour and Welfare for Dovato (dolutegravir 50mg/lamivudine 300mg) two-drug regime...
16 January 2020 - Vision Benefits of America Inc (VBA), a commercial group benefits organisation, has collaborated with Your Hearing Network, a national network of independent hearing care professiona...
14 January 2020 - United States-based ViiV Healthcare has completed a regulatory filing in Europe seeking approval for Fostemsavir intended for the treatment of HIV-1 infection in adult patients havin...
13 January 2020 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has licensed The Rockefeller University's portfolio of broadly neutralizing antibodies (bNAbs) against ...
13 January 2020 - United States-based Gilead Sciences has licensed The Rockefeller University's range of broadly neutralising antibodies (bNAbs) against HIV, including the two clinical-stage agen...
24 December 2019 - - UK-based specialist HIV company ViiV Healthcare, which is majority owned by UK-based pharmaceutical company GlaxoSmithKline plc (NYSE: GSK), with US-based Pfizer Inc. (NYSE: PFE) ...